Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-17 Sale |
2024-06-18 5:18 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,646 | $28.31 | $74,908 | 116,575 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 5:17 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
7,683 | $28.31 | $217,506 | 297,080 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 4:14 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
895 | $24.92 | $22,303 | 57,479 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 4:13 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
2,652 | $24.92 | $66,088 | 145,228 (Direct) |
View |
| 2024-06-03 Purchase |
2024-06-05 8:45 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
130,000 | $21.21 | $2,757,117 | 3,862,697 (Indirect Direct) |
View |
| 2024-06-03 Sale |
2024-06-04 4:20 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
262 | $20.55 | $5,384 | 37,747 (Direct) |
View |
| 2024-05-29 Purchase |
2024-05-31 5:37 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
40,000 | $21.07 | $842,604 | 3,732,697 (Indirect Direct) |
View |
| 2024-05-23 Purchase |
2024-05-28 8:40 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
170,000 | $20.15 | $3,424,989 | 3,692,697 (Indirect Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 6:16 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
50,000 | $23.31 | $1,165,295 | 3,522,697 (Indirect Direct) |
View |
| 2024-04-29 Sale |
2024-04-30 4:30 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,325 | $11.04 | $69,808 | 106,861 (Direct) |
View |
| 2024-04-29 Sale |
2024-04-30 4:27 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
1,104 | $11.04 | $12,185 | 36,862 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:15 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
8,559 | $10.59 | $90,661 | 291,698 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:14 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
2,008 | $10.59 | $21,269 | 90,879 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:14 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
3,253 | $10.59 | $34,455 | 115,290 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 4:28 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
931 | $9.2097 | $8,574 | 24,983 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 4:24 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
2,618 | $9.2097 | $24,111 | 56,507 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 4:22 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
897 | $9.2095 | $8,261 | 26,411 (Direct) |
View |
| 2024-03-04 Purchase |
2024-03-06 7:32 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
40,900 | $8.7446 | $357,652 | 3,472,697 (Indirect Direct) |
View |
| 2024-03-04 Sale |
2024-03-05 4:33 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
301 | $8.57 | $2,580 | 30,625 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 4:10 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
193 | $3.24 | $625 | 26,650 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-04 5:03 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem Chief Transformation Officer |
105 | $2.5799 | $271 | 24,114 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-19 9:26 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
11,734 | $2.1594 | $25,338 | 296,328 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-19 9:25 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem Chief Transformation Officer |
1,700 | $2.1594 | $3,671 | 90,422 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-19 9:24 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin Chief Financial Officer |
2,948 | $2.1594 | $6,366 | 116,595 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 4:06 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
3,673 | $1.6104 | $5,915 | 124,120 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 4:05 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem Chief Transformation Officer |
850 | $1.6104 | $1,369 | 54,622 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-27 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:13 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Meister Keith A. Director 10% Owner |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 7:04 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner |
5,828 | $0 | 3,867,148 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:42 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Leproust Emily M. Director |
5,828 | $0 | 8,352 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:41 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director |
5,828 | $0 | 27,664 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:40 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director |
5,828 | $0 | 202,117 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:39 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Meister Keith A. Director 10% Owner |
5,828 | $0 | 3,647,868 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:18 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
7,197 | $0 | 116,575 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:17 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
18,750 | $0 | 297,080 (Direct) |
View |
| 2024-06-09 Exercise |
2024-06-11 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,462 | $0 | 57,479 (Direct) |
View |
| 2024-06-09 Exercise |
2024-06-11 4:13 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,546 | $0 | 145,228 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:20 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
717 | $0 | 37,747 (Direct) |
View |
| 2024-05-02 Exercise |
2024-05-03 4:04 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director |
918 | $0 | 22,754 (Direct) |
View |
| 2024-04-29 Exercise |
2024-04-30 4:30 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
15,496 | $0 | 106,861 (Direct) |
View |
| 2024-04-29 Exercise |
2024-04-30 4:27 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
3,013 | $0 | 36,862 (Direct) |
View |
| 2024-03-16 Exercise |
2024-03-19 4:15 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
18,750 | $0 | 291,698 (Direct) |
View |
| 2024-03-16 Exercise |
2024-03-19 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
5,114 | $0 | 90,879 (Direct) |
View |
| 2024-03-16 Exercise |
2024-03-19 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
7,197 | $0 | 115,290 (Direct) |
View |
| 2024-03-09 Exercise |
2024-03-12 5:27 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,462 | $0 | 52,997 (Direct) |
View |
| 2024-03-09 Exercise |
2024-03-12 5:26 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
6,547 | $0 | 131,136 (Direct) |
View |
| 2024-03-09 Exercise |
2024-03-12 5:25 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
2,841 | $0 | 58,557 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:33 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
718 | $0 | 30,625 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-23 4:10 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
546 | $0 | 26,650 (Direct) |
View |
| 2024-01-11 Gift |
2024-01-12 4:31 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Ryan Jason Director |
73,614 | $0 | 188,356 (Direct) |
View |
| 2024-01-01 Exercise |
2024-01-03 4:25 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem Chief Transformation Officer |
273 | $0 | 26,674 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 4:23 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Ryan Jason Executive Chairman |
135,560 | $0 | 188,356 (Direct) |
View |
| 2023-12-16 Exercise |
2023-12-19 9:26 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
18,750 | $0 | 296,328 (Direct) |
View |
| 2023-12-16 Exercise |
2023-12-19 9:25 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem Chief Transformation Officer |
5,114 | $0 | 90,422 (Direct) |
View |
| 2023-12-16 Exercise |
2023-12-19 9:24 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin Chief Financial Officer |
7,197 | $0 | 116,595 (Direct) |
View |
| 2023-12-09 Exercise |
2023-12-12 4:06 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,546 | $0 | 124,120 (Direct) |
View |
| 2023-12-09 Exercise |
2023-12-12 4:05 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem Chief Transformation Officer |
2,841 | $0 | 54,622 (Direct) |
View |